EP2600847A1 — Oral pharmaceutical formulations of esomeprazole in the form of mups (multi unit pellets system) tablets
Assigned to Valpharma SpA · Expires 2013-06-12 · 13y expired
What this patent protects
The present invention describes pharmaceutical formulations suitable for oral administration of esomeprazole and methods of preparation to obtain tablets of the MUPS type of adequate hardness with minimum applied compression force. The present invention relates in particular to p…
USPTO Abstract
The present invention describes pharmaceutical formulations suitable for oral administration of esomeprazole and methods of preparation to obtain tablets of the MUPS type of adequate hardness with minimum applied compression force. The present invention relates in particular to pharmaceutical formulations manufactured by production of microgranules containing esomeprazole magnesium dihydrate, which are made resistant to the gastric environment and then compressed, with tableting excipients granulated with water, with applied compression force less than normal for the purpose of obtaining formulations that are stable and resistant to the gastric environment, in the form of MUPS tablets having suitable hardness and low friability.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.